In this podcast, Juandem Agendia and Sarah Alexander (NCTC, UK) discuss bacteriophages, the function of the NCTC and the importance…
In an interview with leaders from Bitscopic, we learn about the predictive model, with a machine learning algorithm that they use to predict the diagnostic fingerprint of COVID-19, using standard laboratory tests.
Infectious Diseases Hub has partnered with Future Virology to bring you exclusive access to articles and features in the recent Special Focus Issue.
In an exclusive interview with an author behind one of the papers published in the recent Future Virology Special Focus Issue, heptatitis and COVID-19 are discussed.
In this interview with Alessandra Renieri we hear about the GEN-COVID network in Italy working to dsicover the genetic variability in COVID-19 patients who show phenotypic differences and what this means for treating the disease.
In this interview we speak to José Javier García from Pivotal about his company´s involvement in a large-scale clinical trial testing the safety and efficacy of hyperimmune convalescent plasma treatment in COVID-19 patients.
Take a peek behind the scenes of a recent article published by Future Virology, titled ‘Pros and cons of the application…
Take a look behind the scenes of a recent Future Virology paper, titled ‘Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection: Let the…
In this interview we speak to Jonathan Kurtis (Brown University, RI, USA) about the discovery of a parasite protein that provides new insights into how malaria regulates infection levels within its host, along with new possibilities for a broadly effective vaccine and a new class of antimalarial drugs.
The coronavirus pandemic presents an immense challenge to the elderly population and those who care for them. We speak to Teena Chopra (Detroit Medical Center and Wayne State University; MI, USA) about her observations regarding COVID-19 infection in the nursing home, including testing strategies, atypical presentation and the future requirements for a robust pandemic response.